Janux Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for PSMAxCD3-TRACTr JANX007 in mCRPC and EGFRxCD3-TRACTr JANX008 in Solid Tumors

SAN DIEGO–(BUSINESS WIRE)—- $JANX–PSMAxCD3-TRACTr JANX007 in mCRPC and EGFRxCD3-TRACTr JANX008 in Solid Tumors
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks